[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Novartis AG
Novartis receives FDA approval for Rhapsido, an oral treatment for chronic spontaneous urticaria. A judge rules on a motion to block a drug-pricing law in Rhode Island, causing market volatility.
About Novartis AG
Novartis AG is a global pharmaceutical company.
Insights #
- Novartis AG engagements is up XXXXXX% from the previous week.
- Novartis AG Price hit a 52-Week high of XXXXXX for the hour
- Novartis AG Price hit an all time of XXXXXX for the hour
Price: $ #
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by the positive news regarding Kesimpta and the company's investments, but the uncertainty around US price cuts and potential tariffs could be creating some volatility, as the price hit an all time high of XXXXXX for the hour.
1-Year High: $XXXXXX on 2025-10-09
1-Year Low: $XX on 2025-04-09
AltRank: undefined #
AltRank 24-Hour Time-Series Raw Data
Novartis AG is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXX on 2025-04-01
1-Year Low: XX on 2025-02-26
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-07
1-Year Low: XX on 2024-12-28
Engagements: XXXXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXXXX +258%
1 Month: XXXXXXXXX -XX%
6 Months: XXXXXXXXXX +75%
1 Year: XXXXXXXXXX +45%
1-Year High: XXXXXXXXX on 2025-08-26
1-Year Low: XXXXXX on 2025-01-27
| Social Network | X | TikTok | YouTube | News | |
|---|---|---|---|---|---|
| Engagements | XXXXXXX | XXXXXX | XXX | XXXXXX | XX |
Mentions: XXX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXXX +33%
1 Year: XXXXXX +149%
1-Year High: XXX on 2025-09-09
1-Year Low: XX on 2024-10-18
| Social Network | X | TikTok | YouTube | News | |
|---|---|---|---|---|---|
| Mentions | XXX | XXX | X | XXX | X |
Creators: XXX #
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Novartis AG in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXX +28%
1 Year: XXXXX +168%
1-Year High: XXX on 2025-09-09
1-Year Low: XX on 2024-10-18
The most influential creators that mention Novartis AG in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ThePlayersTV | X | XXXXX | X | XXXXXXX |
| @theplayerstv | X | XXXXXX | X | XXXXXX |
| @novartis | X | XXXXXX | XX | XXXXX |
| @HealthPolicyW | X | XXXXXX | X | XXXXX |
| @Darwin_Knows | X | XXX | XX | XXXXX |
| @BowTiedBiotech | X | XXXXXX | X | XXX |
| @relebogilepod | X | XXXXXX | X | XXX |
| @MagnetonPlayer2 | X | XXX | X | XXX |
| @ValueSense_io | X | XXXXXX | X | XXX |
| @nucleusmedicalmedia | XX | XXXXXXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -X%
6 Months: XX% -X%
1 Year: XX% -X%
1-Year High: XX% on 2024-10-20
1-Year Low: XX% on 2025-08-26
Most Supportive Themes
- Kesimpta Benefits: (35%) Positive data supporting the benefits of Kesimpta in relapsing multiple sclerosis (RMS) is being shared across multiple social networks.
- Novartis's Innovation and Investment: (20%) Mentions of Novartis's investments in R&D and acquisitions, such as Regulus Therapeutics, are generating positive sentiment.
- Access to Medicines: (15%) Positive sentiment around Novartis's efforts to provide access to medicines, particularly in collaboration with organizations like the UICC.
Most Critical Themes
- US Price Cuts: (10%) Discussions around potential price cuts in the US market, driven by CEO comments and potential tariff impacts, are generating some critical sentiment.
- Patent Revocation: (5%) The revocation of Novartis's patent for Vymada in India is a critical point.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXXX | XX% | XXXXXX | X% | XXX | X% |
| TikTok | XXXXXX | XX% | XXXXX | X% | XXX | X% |
| XXX | X% | X | X% | XX | X% | |
| YouTube | XXXXX | X% | XXXXXX | X% | XX | X% |
| News | XX | X% | X | X% | X | X% |
| Total | XXXXXXX | XX% | XXXXXX | X% | XXXXX | X% |
Market Cap: $undefined #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2024-10-18
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-20
Top assets mentioned In the posts about Novartis AG in the last XX hours
Novartis AG (NVS) Eli Lilly and Company (LLY) Microsoft Corp. (MSFT) IBM (IBM) Pfizer, Inc. (PFE) Sanofi (SNY) Arista Networks Inc (ANET) Palo Alto Networks Inc (PANW) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK)
Top topics mentioned In the posts about Novartis AG in the last XX hours
stocks healthcare, stocks technology, switzerland, eli lilly, stocks, microsoft, ibm, $pfe, sanofi, $novn, india, $anet, $panw, $azn, investment, $mrk, $nesn, south africa, stocks financial services, stocks consumer defensive, $trml, $nvs, $amgn, $ipnpa, $rog, stocks consumer cyclical, $abbv, johnson johnson, tariffs, $googl, stocks communication services, gilead sciences, bloomberg, approved, $qcom, $bud, $abibr, stocks industrials, stocks banks, $sdzsw, $uber, $arwr, united states, has been, ghana, abbott laboratories, hub, taiwan semiconductor, youtube, $issc, jersey, shanghai, $2607hk, $pep, market cap, facebook, donald trump, viatris inc, accenture, the only, $bmy, advanced micro devices, breakthrough, $nvo, insurance, $ubs, $hood, money, instagram, $crnx, over the, why is, $aevssw, $signsw, $kninsw, day of, prize, $rhhby, chronic, momentum, #ai, $sony, greenscreen, fuck you, super bowl, $mar, $telo, $novcde, $14b, $57b, stockmarket, $glue, royal caribbean, $mngl, linkedin, make a, china, london, tiktok, wellness
Top News #
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody"
News Link @YahooFinance 2025-10-13T17:59Z 208.1M followers, XXX engagements
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"GLOBAL DRUG COMPANIES YTD - ASTRA ZENECA +29.20% GSK +21.01% HALEON -XXXX% SANOFI +1.17% ROCHE +11.54% NOVARTIS +16.87% PFIZER -XXXX% MERCK -XXXXX% JOHNSON & JOHNSON +32.52% NOVO NORDISK -XXXXX% BIONTECH -XXXXX% ELI LILLY +4.41% ABBVIE +27.69% TAKEDA +1.39%"
X Link @truemagic68 2025-10-15T05:37Z 49.9K followers, 1277 engagements
"CEO of Palo Alto Networks CEO of Arista Networks CEO of Novartis CEO of Micron Technology CEO of Honeywell CEO of Flex CEO of Wayfair CEO of Zscaler CEO of Chanel CEO of OnlyFans CEO of Motorola Mobility CEO of Cognizant"
X Link @Trendziilla2k 2025-10-15T05:15Z X followers, XX engagements
"#tumor agnostic therapiescritical for rare #cancers. Always ask for #NGS lab work. Their output PDF is our input at #CureMatch. @GuardantHealth @TempusAI @oncodaily @AmgenOncology @Dr_R_Kurzrock @VivekSubbiah @Novartis"
X Link @CureMatch 2025-10-15T04:16Z 1304 followers, XX engagements
"Africa faces a growing malaria threat and rising drug resistance. In some areas only XX% of patients complete the full ACT course fueling resistance. A single dose cure could change that simplifying treatment and save lives. A breakthrough led by @Novartis & @MedsforMalaria"
X Link @damendah 2025-10-15T04:15Z XXX followers, X engagements